HHS announces grants for rural telehealth training to fight opioid abuse

Three states will receive $9 million in grants to help train rural physicians in efforts to fight opioid addiction, HHS announced at the meeting of the National Governors Association.

The agency said the grant recipients may use a model closely related to Project ECHO, a program developed at the University of New Mexico where rural physicians participate with weekly videoconferencing with teams of specialist at academic medical centers, presenting cases and collaborating on treatment options.

The initial efforts were centered on Hepatitis C treatment, but the same methods have been adapted for other diseases. This effort has led to widespread recognition of the model for its potential to improve care in rural areas, such as a Senate proposal introduced in May that would require HHS to analyze whether the ECHO program could work nationally.

POLITICO reported this set of federal grants, specifically targeted at opioid abuse and addiction, will go to 28 counties in Oklahoma, 24 in Colorado and 23 in Pennsylvania.

Anti-opioid abuse efforts were a major focus of the meeting in Washington, D.C. A total of 46 governors signed the “Combat to Fight Opioid Addiction,” pledging to work with healthcare providers to update opioid prescription guidelines, require prescribers to receive extra training on pain management and opioid addiction, and integrate data from state prescription drug monitoring programs into a patient’s electronic health record. 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.